Editors' ChoiceAlzheimer’s Disease

Alzheimer’s medicine: β-Amyloid takes a siP

See allHide authors and affiliations

Science Translational Medicine  14 Dec 2016:
Vol. 8, Issue 369, pp. 369ec200
DOI: 10.1126/scitranslmed.aal3698

Article Information

vol. 8 no. 369 369ec200

DOI: 
https://doi.org/10.1126/scitranslmed.aal3698
PubMed: 
27974660
Published By: 
American Association for the Advancement of Science
Print ISSN: 
1946-6234
Online ISSN: 
1946-6242
History: 
  • .
Copyright & Usage: 
Copyright © 2016, American Association for the Advancement of Science

Author Information

  1. Ian Martin
  1. Department of Neurology, Oregon Health and Science University, Portland, OR 97239, USA. Email: martiia{at}ohsu.edu

Altmetric

Article usage

Article usage: December 2016 to January 2020

AbstractFullPdf
Dec 201605066
Jan 20170570
Feb 20170790
Mar 20170530
Apr 20170520
May 20170370
Jun 20170220
Jul 20170300
Aug 20170360
Sep 20170380
Oct 20170560
Nov 20170370
Dec 20170330
Jan 20180140
Feb 20180140
Mar 20180310
Apr 20180654
May 20180330
Jun 20180440
Jul 20180250
Aug 20180120
Sep 20180100
Oct 20180140
Nov 20180330
Dec 20180300
Jan 20190141
Feb 20190360
Mar 20190440
Apr 20190250
May 2019070
Jun 20190160
Jul 20190130
Aug 20190290
Sep 20190140
Oct 20190191
Nov 20190200
Dec 20190170
Jan 20200180

View Full Text

Article Tools

  • Email

  • Alerts
  • Citation tools

  • Alzheimer’s medicine: β-Amyloid takes a siP

    By Ian Martin

    Science Translational Medicine : 369ec200

    Disrupting the binding of β-amyloid oligomers to EphB2 receptor using a small interfering peptide is neuroprotective in a mouse model of Alzheimer’s disease.

    CiteULike logo Connotea logo del.icio.us logo Digg logo Facebook logo Google logo Mendeley logo Reddit logo Twitter logo

Stay Connected to Science Translational Medicine

Related Content

Similar Articles in:

Citing Articles in:

Navigate This Article